4:38 PM · 15 July 2025

US bank stocks down despite strong earnings reports 📉JP Morgan loses -1%

JPMorgan Chase
Stocks
JPM.US, JPMorgan Chase & Co
-
-
Wells Fargo
Stocks
WFC.US, Wells Fargo & Co
-
-
Citigroup
Stocks
C.US, Citigroup Inc
-
-

U.S. bank stocks kicked off earnings season on Wall Street today and are trading lower, despite all institutions delivering very solid results, reporting earnings per share significantly above expectations. Revenues also beat Wall Street forecasts. However, the market is pricing in a series of interest rate cuts in 2026, and possibly even a first cut later this year, which leads investors to react somewhat cautiously to the current figures. They see them as difficult to sustain in the medium term if rates decline, reducing lenders' profitability. As for now, strong bank earnings reports suggest profit-taking in pre-market hours.

JPMorgan (JPM.US) Q2 2025 Earnings

Not only did JPMorgan deliver a strong report, but even its significantly higher forecast for net interest income failed to lift shares of the largest U.S. bank. Before the U.S. market open, the stock is down around 1%, although the final market reaction will become clearer once the session begins.

  • Earnings per share (EPS): $5.24 vs Est. $4.47

  • Adjusted revenue: $45.68B vs Est. $44.05B

  • Provision for credit losses: $2.85B, Est. $3.22B

  • Return on equity (ROE): 18%, Est. 15.1%

  • Cash and due from banks: $23.76B, Est. $22.07B

  • Standardized CET1 ratio: 15%, Est. 15.4%

  • Managed net interest income: $23.31B, Est. $23.59B

  • Total deposits: $2.56T, Est. $2.5T

  • Loans: $1.41T, Est. $1.36T

  • Net charge-offs: $2.41B, Est. $2.46B

  • Equities sales & trading revenue: $3.25B, Est. $3.2B

  • Investment banking revenue: $2.68B, Est. $2.16B

  • FICC sales & trading revenue (fixed income, currencies, commodities): $5.69B, Est. $5.22B

  • FY net interest income forecast: approx. $95.5B (previously projected at approx. $94.5B)

Source: xStation5

Wells Fargo (WFC.US) Q2 2025 Earnings

  • Earnings per share (EPS): $1.60 vs Est. $1.41

  • Revenue: $20.82B vs Est. $20.75B

  • Net interest income: $11.71B, Est. $11.83B

  • Non-performing assets (NPA): $7.96B, Est. $8.68B

  • Non-interest expenses: $13.38B, Est. $13.4B

  • Provision for credit losses: $1.01B, Est. $1.16B

  • Total average deposits: $1.33T, Est. $1.35T

  • Investment banking fees: $696M, Est. $703.1M

  • FY net interest income forecast: approx. $47.7B, Est. $47.92B

Citigroup (C.US) Q2 2025 Earnings

  • Earnings per share (EPS): $1.96 vs Est. $1.60

  • Revenue: $21.67B vs Est. $21B

  • Adjusted FY revenue forecast: approx. $84B (previous guidance: $83.1B–$84.1B)

  • FICC sales & trading revenue (fixed income, currencies, commodities): $4.27B, Est. $3.92B

  • Investment banking revenue: $1.92B, Est. $1.65B

  • Equities sales & trading revenue: $1.61B, Est. $1.55B

  • Net interest income: $15.18B, Est. $14.05B

10 October 2025, 8:51 PM

Applied Digital accelerates growth. Shares rise by nearly 20%.

10 October 2025, 12:52 PM

DAX: DE40 tries to hold the momentum 📈Brenntag and ArcelorMittal under pressure

9 October 2025, 7:13 PM

Delta Airlines stock lifts off after earnings✈️

9 October 2025, 6:34 PM

Stock of the Week - Super Micro Computer (09.10.2025)

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

Join over 1 700 000 investors from around the world